NSE ScannerInsurance · Life/Health Insurance · NSE: STARHEALTH · data 2026-10-31
Star Health & Allied Insurance Co. Ltd.
In plain words
Price: 15.1% below its 52-week high of ₹624.9.
Delivery: 58.1% of traded shares were kept for delivery over the last 10 sessions, against 57.4% over the last 60.
Latest results: a net profit of ₹265 cr for the quarter ended Sept 2026 (+382.3% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹19,907 cr |
| Net profit (last 12 months) | ₹1,054 cr |
| Sales growth, 3 years (yearly) | 13.8% |
| Profit growth, 3 years (yearly) | -3.4% |
At a glance
Promoters 58.0% (unchanged in a year), pledged 0.0%, institutions 34.6%.
P/E 29.6, P/B 3.0, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 7.6%, operating margin 6.1%: how much profit it earns on the money it uses.
Profit growth -3.4% and sales growth 13.8% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (7.6%).
- Profit fell 3.4% a year over 3 years.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q2 FY27)
STARHEALTH Q2 FY27 results (standalone figures, as filed on NSE).
Net profit was ₹264.81 crore, up 382.3% YoY and down 51.8% QoQ.
EPS was ₹4.5, up 389.1% YoY and down 51.8% QoQ.
STARHEALTH के Q2 FY27 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
शुद्ध मुनाफ़ा: ₹264.81 करोड़; पिछले साल की तुलना में 382.3% की बढ़त, पिछली तिमाही की तुलना में 51.8% की गिरावट।
EPS: ₹4.5; पिछले साल की तुलना में 389.1% की बढ़त, पिछली तिमाही की तुलना में 51.8% की गिरावट।
STARHEALTHના Q2 FY27 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
ચોખ્ખો નફો: ₹264.81 કરોડ; ગયા વર્ષની સરખામણીએ 382.3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 51.8% ઘટાડો.
EPS: ₹4.5; ગયા વર્ષની સરખામણીએ 389.1% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 51.8% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
21/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 4/30: Delivery 63.4% over the last 20 sessions vs 68.5% in the 40 before (0.93x); shares delivered per day 0.75x usual; 1 delivery-spike day (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 11/15: 13 schemes hold it, about ₹1,344 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 1/15: Verdict "None", sustained score 27/100.
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results
- 27 Oct 26Results Q2 FY27 results: profit +382.3% YoY -3.5% next session
- 20 Oct 26Results Q1 FY27 results: profit +109.4% YoY 0.0% next session
- 28 Apr 26Results Q4 FY26 results: profit +21729.4% YoY +3.4% next session
- 28 Jan 26Results Q3 FY26 results: net profit ₹128.2 cr +6.0% next session
- 28 Oct 25Results Q2 FY26 results: net profit ₹54.9 cr -1.4% next session
- 29 Jul 25Results Q1 FY26 results: net profit ₹262.5 cr +5.7% next session
- 30 Apr 25Results Q4 FY25 results: net profit ₹0.5 cr -5.2% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Sept 2026 | — | ₹265 cr | +382.3% | — | 4.5 |
| Jun 2026 | — | ₹550 cr | +109.4% | — | 9.34 |
| Mar 2026 | ₹4,327 cr | ₹111 cr | +21729.4% | — | 1.89 |
| Dec 2025 | ₹4,250 cr | ₹128 cr | — | — | 2.18 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 58.00% | 58.01% | 57.98% | 57.98% |
| Foreign institutions (FII) | 15.85% | 16.04% | 15.05% | 14.07% |
| Domestic institutions (DII) | 18.77% | 19.41% | 20.31% | 20.96% |
| Mutual funds | 10.43% | 10.27% | 11.93% | 12.95% |
| Retail investors | 2.84% | 2.55% | 2.62% | 2.79% |
| Number of shareholders | 1,66,756 | 1,68,763 | 1,79,067 | 1,86,448 |
Common questions
What was Star Health & Allied Insurance Co. Ltd.'s latest quarterly profit?
Star Health & Allied Insurance Co. Ltd. reported a net profit of ₹265 cr for the quarter ended Sept 2026 (+382.3% on the same quarter a year earlier), on revenue of —.
How much do promoters hold in Star Health & Allied Insurance Co. Ltd.?
Promoters held 58.00% of Star Health & Allied Insurance Co. Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Star Health & Allied Insurance Co. Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.06, which is very low.
What is Star Health & Allied Insurance Co. Ltd.'s P/E ratio?
About 29.7, based on the last 12 months' earnings and a price of ₹530.4 (data 2026-10-31).
What is the 52-week high and low of Star Health & Allied Insurance Co. Ltd.?
The 52-week high is ₹624.9 and the 52-week low is ₹416.55.
Mutual funds holding Star Health & Allied Insurance Co. Ltd.
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 13 schemes holding about ₹1,344 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI Balanced Advantage Fund | SBI Mutual Fund | 1.28% | ₹519 cr |
| SBI Midcap Fund | SBI Mutual Fund | 1.45% | ₹338 cr |
| SBI Banking And Financial Services Fund | SBI Mutual Fund | 1.71% | ₹178 cr |
| NIPPON INDIA BANKING & FINANCIAL SERVICES FUND | Nippon India Mutual Fund | 2.04% | ₹150 cr |
| Nippon India Balanced Advantage Fund | Nippon India Mutual Fund | 0.85% | ₹81 cr |
| ADITYA BIRLA SUN LIFE BANKING AND FINANCIAL SERVICES FUND | Aditya Birla Sun Life Mutual Fund | 0.97% | ₹33 cr |
| Nippon India Nifty Smallcap 250 Index Fund | Nippon India Mutual Fund | 0.56% | ₹19 cr |
| Nippon India Active Momentum Fund | Nippon India Mutual Fund | 2.53% | ₹15 cr |
| SBI Nifty Smallcap 250 Index Fund | SBI Mutual Fund | 0.56% | ₹10 cr |
| Mirae Asset Nifty Smallcap 250 ETF | Mirae Asset Mutual Fund | 0.56% | ₹1 cr |
| Mirae Asset BSE Select IPO ETF | Mirae Asset Mutual Fund | 0.92% | ₹0 cr |
| Nippon India Nifty 500 Low Volatility 50 Index Fund | Nippon India Mutual Fund | 0.36% | ₹0 cr |
| SBI Nifty Small Cap 250 ETF | SBI Mutual Fund | 0.56% | ₹0 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Star Health & Allied Insurance Co. Ltd. | ₹530.4 | ₹31,215 cr | 29.7 | 3 | 7.6% | 4.6% | 0.06 | +10.3% |
| HDFC Life Insurance Co. Ltd. | ₹524.9 | ₹1,13,659 cr | 55.4 | 5.9 | 11.3% | 0.6% | 0.17 | -30.8% |
| ICICI Life Insurance Ltd | ₹410 | ₹59,356 cr | 37.1 | 4.4 | 12.6% | 0.6% | 0.19 | -31.8% |
| Max Financial Services Limited | ₹1,200 | ₹41,517 cr | 221.9 | 7.2 | 1.6% | — | 0.44 | -21.0% |
| Niva Bupa Health Insurance Company Limited | ₹72.65 | ₹13,432 cr | 37.6 | 3.5 | 10% | 9.8% | 0.1 | -3.5% |
| Canara HSBC Life Insurance Company Limited | ₹121.41 | ₹11,519 cr | 36 | 7 | 8.1% | 0.2% | 0.16 | +3.8% |
Compare STARHEALTH with HDFCLIFE in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open STARHEALTH in NSE Scanner →